Apyx Medical Corp (APYX) Gross Margin
- Gross margin · 12 months: Value 63.50%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 63.50% | Gross profit / revenue. Period ending 2026-06-30. $37.09M ÷ $58.41M × 100 ≈ 63.50% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 37.09M USD | Gross Profit |
| Revenue | 58.41M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 21.32M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $37.09M | $58.41M | $21.32M | 63.50% |
| 2026-03-31 | $35.30M | $55.90M | $20.60M | 63.15% |
| 2025-12-31 | $33.04M | $52.84M | $19.80M | 62.53% |
| 2025-09-30 | $30.01M | $47.90M | $17.89M | 62.65% |
| 2025-06-30 | $28.67M | $46.51M | $17.85M | 61.63% |
| 2025-03-31 | $29.08M | $47.29M | $18.21M | 61.49% |
| 2024-12-31 | $29.36M | $48.10M | $18.74M | 61.04% |
| 2024-09-30 | $29.32M | $48.54M | $19.22M | 60.41% |
| 2024-06-30 | $30.35M | $49.03M | $18.68M | 61.90% |
| 2024-03-31 | $32.13M | $50.45M | $18.32M | 63.70% |
| 2023-12-31 | $33.76M | $52.35M | $18.59M | 64.49% |
| 2023-09-30 | $33.07M | $50.30M | $17.23M | 65.75% |
| 2023-06-30 | $30.85M | $47.44M | $16.59M | 65.03% |
| 2023-03-31 | $28.48M | $44.16M | $15.67M | 64.51% |
| 2022-12-31 | $29.13M | $44.51M | $15.38M | 65.45% |
| 2022-09-30 | $33.04M | $48.72M | $15.68M | 67.81% |
| 2022-06-30 | $35.34M | $51.44M | $16.10M | 68.70% |
| 2022-03-31 | $35.96M | $52.37M | $16.41M | 68.66% |
| 2021-12-31 | $33.60M | $48.52M | $14.92M | 69.26% |
| 2021-09-30 | $29.15M | $43.16M | $14.01M | 67.55% |
| 2021-06-30 | $25.82M | $38.28M | $12.46M | 67.45% |
| 2021-03-31 | $20.38M | $31.35M | $10.97M | 65.00% |
| 2020-12-31 | $17.50M | $27.71M | $10.21M | 63.17% |
| 2020-09-30 | $15.37M | $24.63M | $9.26M | 62.39% |
| 2020-06-30 | $15.94M | $25.25M | $9.31M | 63.11% |
| 2020-03-31 | $18.52M | $27.60M | $9.09M | 67.08% |
| 2019-12-31 | $19.09M | $28.23M | $9.14M | 67.63% |
| 2019-09-30 | $16.54M | $25.70M | $9.16M | 64.36% |
| 2019-06-30 | $14.24M | $21.99M | $7.75M | 64.74% |
| 2019-03-31 | $12.30M | $19.11M | $6.81M | 64.36% |
| 2018-12-31 | $10.79M | $16.69M | $5.89M | 64.68% |
| 2018-09-30 | $22.77M | $43.07M | $20.30M | 52.87% |
| 2018-06-30 | $21.76M | $42.09M | $20.33M | 51.70% |
| 2018-03-31 | $20.52M | $40.41M | $19.89M | 50.79% |
| 2017-12-31 | $19.76M | $38.88M | $19.12M | 50.82% |
| 2017-09-30 | $18.69M | $37.03M | $18.34M | 50.48% |
| 2017-06-30 | $19.16M | $37.74M | $18.58M | 50.76% |
| 2017-03-31 | $18.82M | $37.24M | $18.42M | 50.53% |
| 2016-12-31 | $17.91M | $36.63M | $18.71M | 48.91% |
| 2016-09-30 | $16.60M | $35.43M | $18.83M | 46.85% |
| 2016-06-30 | $14.77M | $33.19M | $18.42M | 44.49% |
| 2016-03-31 | $13.21M | $31.17M | $17.96M | 42.37% |
| 2015-12-31 | $12.56M | $29.52M | $16.96M | 42.54% |
| 2015-09-30 | $11.48M | $28.69M | $17.21M | 40.02% |
| 2015-06-30 | $10.17M | $27.66M | $17.48M | 36.78% |
| 2015-03-31 | $8.91M | $27.33M | $18.42M | 32.61% |
| 2014-12-31 | $8.99M | $27.68M | $18.69M | 32.48% |
| 2014-09-30 | $9.12M | $26.34M | $17.22M | 34.62% |
| 2014-06-30 | $9.45M | $25.35M | $15.90M | 37.28% |
| 2014-03-31 | $9.80M | $24.45M | $14.64M | 40.10% |
| 2013-12-31 | $9.20M | $23.66M | $14.46M | 38.88% |
| 2013-09-30 | $9.42M | $24.36M | $14.94M | 38.66% |
| 2013-06-30 | $10.06M | $25.24M | $15.17M | 39.87% |
| 2013-03-31 | $10.69M | $26.63M | $15.95M | 40.13% |
| 2012-12-31 | $11.33M | $27.67M | $16.34M | 40.96% |
| 2012-09-30 | $11.19M | $27.00M | $15.81M | 41.45% |
| 2012-06-30 | $10.90M | $26.59M | $15.68M | 41.01% |
| 2012-03-31 | $11.09M | $25.99M | $14.90M | 42.69% |
| 2011-12-31 | $10.73M | $25.41M | $14.68M | 42.23% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $9.99M | $24.23M | $14.24M | 41.22% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2009-12-31 | $11.86M | $26.95M | $15.10M | 43.98% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |